Treatment of cardiovascular pathology with epigenetically active agents: Focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation
Epigenetic mechanisms involve heritable changes in gene expression. Pathogenesis of epigenetic cardiovascular diseases (CVDs) is associated with global genome-wide changes. Modulation of epigenetic CVD mechanisms can be achieved by administration epigenetically active agents.